Molecular-structure (Lamotrigine Extended Release Tablets 1)
Lamotrigine Tablet, Film Coated, Extended Release
Product Images NDC 10370-207
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 10370-207). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Lamotrigine Extended Release Tablets 2)
This text appears to be describing a comparative study of responder rates for patients using a placebo versus lamotrigine extended-release tablets. The responder rate, defined as equal or greater improvement, was evaluated in a group of 73 patients who received a placebo and a group of 70 patients who took lamotrigine extended-release tablets. The results are depicted in a graph showing the percentage of patients experiencing improvement in different categories.*
Figure-2 (Lamotrigine Extended Release Tablets 3)
This text provides information on the responder rate, improvement, and worsening in a clinical trial comparing Lamotrigine Extended-Release Tablets to a placebo. The chart shows percentages of patients in different categories, but specific details are not available.*
Lamo Tabs (Lamotrigine Extended Release Tablets 4)
This is a description of tablets of different dosages and colors. The tablets come in 100 mg orange, 200 mg blue, 250 mg white to off-white, and 300 mg gray variations. They are round, oval, or shaped tablets, film-coated with speckles and imprinted with different codes like "A208", "A207", "A334", and "A256". The tablets have one side imprinted with the code in black ink and the other side plain.*
100 mg 30s (Lamotrigine Extended Release Tablets 5)
This text provides information about a medication labeled as NDC 10370-207-11, which is once-a-day Lamotrigine Extended-Release Tablets (100 mg). The text includes directions for pharmacists, caution statements, dosage information, storage instructions, and the manufacturer's details. Patients are advised to keep the drug out of reach of children. The medication guide should be dispensed with each prescription.*
200 mg 30s (Lamotrigine Extended Release Tablets 6)
This text provides information about a medication called Lamotrigine extended-release tablets in 200 mg strength. The usual dosage and storage instructions are mentioned, along with a caution to verify the product dispensed. It also instructs to keep the drug out of reach of children and includes details for pharmacists to provide a Medication Guide to each patient. The manufacturer is indicated as Endo USA.*
250 mg 30s (Lamotrigine Extended Release Tablets 7)
Description: This text is a label or insert for the medication Lamotrigine Extended-Release Tablets with a strength of 250 mg. It includes important information such as dosage instructions, storage conditions, and a caution to verify the product dispensed. The pharmacist is instructed to dispense a Medication Guide to each patient. The text also mentions keeping the drug out of reach of children and ensuring the safety seal is intact before use. It provides a neutral code and identifies the manufacturer as Endo USA.*
300 mg 30s (Lamotrigine Extended Release Tablets 8)
This is a description of Lamotrigine Extended-Release Tablets, with each tablet containing 300 mg of lamotrigine. It is a prescription medication for once-a-day use. The packaging includes 30 tablets and a pharmacist is instructed to dispense a Medication Guide to each patient. The dosage information is available in the package insert. The medication should be kept out of reach of children, stored in a light-resistant container at room temperature, and not used if the safety seal is broken or missing. The tablets are manufactured for Endo USA, located in PA 19355, U.S.A.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
